Tuesday 15 September 2020

MRFF Consultation - Medical Research and Innovation Priorities 2020-2022

A national consultation process is now underway to guide the third set of the MRFF- Australian Medical Research and Innovation Priorities for 2020–2022. 

Shortly, there will be Monash Town Hall Meetings to provide further information and to gather input for a Monash response. Please consider registering to attend one of these events and have your say as these are important pillars to the MRFF framework.

The wide consultation is open to the Australian public, organisations with expertise in health and medical research and innovation, consumer representatives, clinicians and health services managers.

This is your chance to have input into the consultation process around setting the MRFF Priorities for the next 2 years. Time is short as the consultation ends Oct 7th 2020 so meetings will be planned for later this month.

MRFF Priorities are designed in accordance with the MRFF Act with the purpose of informing Government decision-making on future initiatives. The Priorities are considered by the Minister for Health before the Commonwealth Government decides on the disbursement of funding from the MRFF. For these reasons it is important that we are engaged in the development of the new MRFF Priorities. 

Please find below: 

The current MRFF Priorities  

The current MRFF Priorities are listed below. The Priorities are shown at the bold font dot points while the underline headings represent the MRFF Strategies that relate to these priorities.

NOTE: it is likely that many of the Priorities may remain, as they are not necessarily replaced every two years, but they are reviewed and refreshed.  

Strategic and International Horizons

  • One Health - Antimicrobial Resistance
  • Global Health and Health Security
  • Aboriginal and Torres Strait Islander Health
  • Ageing and Aged Care

Data and Infrastructure

  • Digital Health Intelligence

Health Services and Systems

  • Comparative Effectiveness Research
  • Primary Care Research

Capacity and Collaboration

  • Clinical Researcher Capacity
  • Consumer-Driven Research

Trials and Translation

  • Drug Repurposing
  • Public Health Interventions

Commercialisation

  • Translational Research Infrastructure

No comments:

Post a Comment